What We Do
We build and operate, not just invest.
G3 Genomics is a venture studio focused exclusively on life science tools, diagnostics, and genomics. We own and support a portfolio of independent operating companies that design, manufacture, and commercialize molecular reagents, platforms, and services for laboratories worldwide.
Our work spans three areas:
Company Formation and Structured Acquisitions
We create new operating companies and execute targeted asset acquisitions — capturing strong technologies and product lines and placing them into clean, properly capitalized structures with clear governance from day one.
Embedded Operating Support
Our studio team works directly inside each portfolio company, providing finance, capital strategy, quality systems, and commercial execution. Portfolio companies get the benefit of an experienced operating bench without the overhead of building it independently.
Capital‑Efficient Growth
We prioritize recurring consumables revenue, disciplined cost structure, and clear unit economics. We build businesses that grow on product traction, not burn rate.
Why Molecular Diagnostic Tools & Genomics
The market is large, fragmented, and ready for focused operators.
Molecular diagnostics and genomics tools represent a large and growing market as qPCR and NGS become standard infrastructure across clinical, research, and industrial laboratory settings. Yet many product lines remain under‑optimized — strong technologies constrained by limited commercial attention, legacy capital structures, or fragmented ownership.
G3 focuses on:
· Proven consumables businesses with recurring revenue and room for focused commercial growth.
· Technologies with meaningful IP positions that can expand access to molecular testing.
· Structured acquisitions that unlock value trapped in misaligned or distressed corporate situations.
Built for the lab bench and the boardroom
Every G3 portfolio company is a separate legal entity with its own leadership, contracts, and financials. G3 provides shared operating expertise and capital at the studio level.
Portfolio Overview
CrestForge Inc
Molecular Platforms and Reagent Manufacturing
CrestForge is the innovation and manufacturing engine of the G3 portfolio. It develops the advanced molecular diagnostics platform, NGS library preparation, and provides contract manufacturing services for reagent kits and molecular products.
Bandit Bio (Bandit Biosystems Inc)
Precision Reagents for Modern Laboratories
Bandit Bio develops and supplies SeqOnce™ qPCR assay panels and NGS library preparation kits for research and clinical laboratories. Built on a proven product platform with an expanding assay menu, Bandit Bio delivers reproducible performance, streamlined workflows, and transparent economics to labs that need reagents they can depend on.
Stealth Co 1
Consumer focused molecular and genetics testing company - Launching Q3 2026